Thomas Schmid, a leading partner in the Munich office of Weil, Gotshal & Manges, is joining Orrick, Herrington & Sutcliffe as head of the firm’s German M&A and Private Equity Group, Orrick announced on Wednesday.
At Weil, Schmid worked on a number of high-profile deals: he represented German biotech company MorphoSys in the acquisition of Dutch biopharmaceutical company Lanthio Pharma , and advised EQT Expansion Capital II Fund in its investment in UDG United Digital Group .
“We looked out into the market for someone who could plug into our platform and excel. Thomas was one of the first corporate lawyers that ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
